(TTRX - TURN THERAPEUTICS INC)

company profile

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Turn Therapeutics (TTRX) is trading at 12.69

Open Price
13.3
Previous close
12.69
Previous close
12.69
P/E Ratio
0
Sector
Health Care
Shares outstanding
30502704
Primary exchange
NASDAQ-NMS
ISIN
US90021W1053